Clinical Trials Directory

Trials / Unknown

UnknownNCT00515658

Antidepressant Effect of Theta-Burst rTMS

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the safety and efficacy of theta-burst rTMS in patients with major depression. Patients will be randomized to receive ether left-sided intermittent theta-burst rTMS or rigt-sided continuous theta-burst rTMS or sham theta-burst rTMS over two weeks period with an option for an additional two weeks period, depending on treatment response. Clinical assessments will be performed weekly by the Hamilton depression rating scale. In addition, standard neurophysiological assessment of cortical excitability will be done.

Conditions

Interventions

TypeNameDescription
DEVICEtheta-burst rTMS

Timeline

Start date
2007-03-01
First posted
2007-08-14
Last updated
2007-08-14

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00515658. Inclusion in this directory is not an endorsement.

Antidepressant Effect of Theta-Burst rTMS (NCT00515658) · Clinical Trials Directory